These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15286068)

  • 1. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial.
    Gray R; Wykes T; Edmonds M; Leese M; Gournay K
    Br J Psychiatry; 2004 Aug; 185():157-62. PubMed ID: 15286068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of medication management training on community mental health nurse's clinical skills.
    Gray R; Wykes T; Gournay K
    Int J Nurs Stud; 2003 Feb; 40(2):163-9. PubMed ID: 12559140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can training community mental health nurses to support family carers reduce behavioural problems in dementia? An exploratory pragmatic randomised controlled trial.
    Moniz-Cook E; Elston C; Gardiner E; Agar S; Silver M; Win T; Wang M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):185-91. PubMed ID: 17621379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication management for people with a diagnosis of schizophrenia.
    Gray R; Robson D; Bressington D
    Nurs Times; 2002 Nov 19-25; 98(47):38-40. PubMed ID: 12494838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of a medication management training programme for community mental health professionals; service user level outcomes: a cluster randomised controlled trial.
    Harris N; Lovell K; Day J; Roberts C
    Int J Nurs Stud; 2009 May; 46(5):645-52. PubMed ID: 19070855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence therapy following acute exacerbation of schizophrenia: A randomised controlled trial in Thailand.
    von Bormann S; Robson D; Gray R
    Int J Soc Psychiatry; 2015 Feb; 61(1):3-9. PubMed ID: 24691494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.
    Németh G; Laszlovszky I; Czobor P; Szalai E; Szatmári B; Harsányi J; Barabássy Á; Debelle M; Durgam S; Bitter I; Marder S; Fleischhacker WW
    Lancet; 2017 Mar; 389(10074):1103-1113. PubMed ID: 28185672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial.
    Schulz M; Gray R; Spiekermann A; Abderhalden C; Behrens J; Driessen M
    Schizophr Res; 2013 May; 146(1-3):59-63. PubMed ID: 23452506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice nurses and the care of patients receiving depot neuroleptic treatment: views on training, confidence and use of structured assessment.
    Millar E; Garland C; Ross F; Kendrick T; Burns T
    J Adv Nurs; 1999 Jun; 29(6):1454-61. PubMed ID: 10354241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
    Gharabawi GM; Greenspan A; Rupnow MF; Kosik-Gonzalez C; Bossie CA; Zhu Y; Kalali AH; Awad AG
    BMC Psychiatry; 2006 Oct; 6():45. PubMed ID: 17054789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
    Constantine RJ; Andel R; McPherson M; Tandon R
    Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
    Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
    Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Davidson M; Saoud J; Staner C; Noel N; Luthringer E; Werner S; Reilly J; Schaffhauser JY; Rabinowitz J; Weiser M; Luthringer R
    Am J Psychiatry; 2017 Dec; 174(12):1195-1202. PubMed ID: 28750582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing focus of mental health nursing in east London.
    Mathers B; Howard C
    Br J Community Nurs; 2000 Nov; 5(11):566-71. PubMed ID: 12066056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.